12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga13:05 ET

Bluebird Bio Shares Rise After Non-Binding Offer From Ayrmid

WSJMar 31 11:48 ET

Gene Therapy-Focused Bluebird Bio Receives Rival Takeover Offer, Stock Jumps

BenzingaMar 31 11:24 ET

Bluebird Bio Is Maintained at Overweight by Barclays

Dow JonesMar 31 10:53 ET · Ratings

Bluebird Bio Receives $4.50 Per Share Acquisition Proposal From Ayrmid

RTTNewsMar 31 10:44 ET

Barclays Maintains Overweight on Bluebird Bio, Lowers Price Target to $8

BenzingaMar 31 10:43 ET · Ratings